Parathyroid Hormone Global Market Report 2025

Description

Parathyroid hormone, produced by the parathyroid gland, plays a crucial role in the body's calcium storage and utilization. Elevated levels of this hormone can lead to high blood calcium levels, potentially indicating a medical condition. It's also referred to as PTH, parathyrin, or parathormone.

Within the realm of parathyroid hormone products, there are recombinant parathyroid hormone and parathyroid hormone analogs. Recombinant parathyroid hormone, resembling natural parathyroid hormone, is utilized in treating osteoporosis. These products cater to conditions like hypocalcemia and hypoparathyroidism and are used across various healthcare settings such as hospitals, clinics, and others.

The parathyroid hormone market research report is one of a series of new reports from The Business Research Company that provides parathyroid hormone market statistics, including parathyroid hormone industry global market size, regional shares, competitors with a parathyroid hormone market share, detailed parathyroid hormone market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid hormone industry. This parathyroid hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The parathyroid hormone market size has grown steadily in recent years. It will grow from $2.35 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, increasing awareness of parathyroid hormone-related disorders, growing demand for parathyroid hormone analogs, increased government funding for parathyroid hormone research, rising disposable incomes.

The parathyroid hormone market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growing geriatric population, expansion of private healthcare sectors, emerging indications, precision medicine, growing awareness of bone health, expanding healthcare access. Major trends in the forecast period include advances in parathyroid hormone testing, advances in drug delivery, combination therapies, digital health integration, sustainability and green initiatives.

The market for parathyroid hormones anticipates growth due to rising osteoporosis prevalence. In January 2021, Osteoporosis, characterized by reduced bone mass leading to higher fracture risks, affects approximately 1.4 million Canadians, primarily postmenopausal women and the elderly. Parathyroid hormones, regulating calcium levels, are administered via daily subcutaneous injections to mitigate fracture risks in osteoporosis patients. This surge in osteoporosis cases is expected to contribute to the expansion of the parathyroid hormone market.

The growing geriatric population is expected to drive the growth of the parathyroid hormone market in the future. The geriatric population refers to older adults, typically aged 65 and older, who may face age-related health challenges and require specialized care and support. This demographic shift is largely due to increased life expectancy, advancements in healthcare, and declining birth rates, leading to a larger proportion of elderly individuals in society. Parathyroid hormone plays a crucial role for this demographic as it regulates calcium levels and bone metabolism, helping to prevent conditions such as osteoporosis and fractures, which are prevalent among older adults. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Additionally, this age group's share of the total population is expected to grow from 17% to 23% during the same period. Therefore, the increasing geriatric population is driving the expansion of the parathyroid hormone market.

Major companies in the parathyroid hormone market are increasingly focused on developing biosimilars of parathyroid-based drugs, such as prodrugs of parathyroid hormone (PTH), to expand treatment options. A prodrug of parathyroid hormone is an inactive compound that converts into active PTH after administration, allowing for prolonged release and stable therapeutic outcomes in calcium regulation and bone health. For example, in August 2024, Ascendis Pharma A/S, a biopharmaceutical company based in Denmark, announced that the Food and Drug Administration (FDA) approved YORVIPATH (palopegteriparatide) as the first and only treatment for hypoparathyroidism in adults. This once-daily prodrug ensures continuous exposure to PTH, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma supports patients through its Ascendis Signature Access Program (A.S.A.P.), although users must regularly monitor their serum calcium levels to detect potential hypercalcemia or hypocalcemia.

Major companies in the parathyroid hormone market are concentrating on innovative solutions, such as prodrugs, to enhance drug performance. A prodrug is an inactive compound that is metabolically converted into an active drug within the body. For example, in August 2022, Ascendis Pharma A/S, a biopharmaceutical company based in Denmark, submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational therapy, TransCon PTH (palopegteriparatide), intended for treating adult patients with hypoparathyroidism. TransCon PTH is a long-acting prodrug of parathyroid hormone designed to restore physiological PTH levels over a 24-hour period. This is essential for managing hypoparathyroidism, a condition characterized by insufficient parathyroid hormone production, which results in low calcium levels and related health complications.

Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, announced its decision to acquire Shire Plc for $46 billion. The acquisition is expected to accelerate the delivery of medicines to patients around the world with an expanded scale and geographical footprint by Takeda Pharmaceutical Company. It also increases the levels of the parathyroid hormone, natpara. Shire Plc is a pharmaceutical company based in the United States that specializes in innovative and rare disease drugs.

Major companies operating in the parathyroid hormone market include Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

North America was the largest region in the parathyroid hormone market in 2024. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The parathyroid hormone market consists of sales of parathormone and calcitonin. Values in this market are ''factory gate values,'' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Parathyroid Hormone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on parathyroid hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for parathyroid hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The parathyroid hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease Type: Hypocalcemia; Hypoparathyroidism
2) By Product Type: Recombinant Parathyroid Hormone; Parathyroid Hormone Analogues
3) By End-User: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Hypocalcemia: Pseudohypoparathyroidism; Vitamin D Deficiency
2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism; Idiopathic Hypoparathyroidism
Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Radius Health Inc.; Ascendis Pharma; Entera Bio Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32948

1. Executive Summary

2. Parathyroid Hormone Market Characteristics

3. Parathyroid Hormone Market Trends And Strategies

4. Parathyroid Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Parathyroid Hormone Growth Analysis And Strategic Analysis Framework

5.1. Global Parathyroid Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Parathyroid Hormone Market Growth Rate Analysis
5.4. Global Parathyroid Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Parathyroid Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Parathyroid Hormone Total Addressable Market (TAM)

6. Parathyroid Hormone Market Segmentation

6.1. Global Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypocalcemia
Hypoparathyroidism
6.2. Global Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Parathyroid Hormone
Parathyroid Hormone Analogues
6.3. Global Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End-Users
6.4. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypocalcemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pseudohypoparathyroidism
Vitamin D Deficiency
6.5. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypoparathyroidism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Post-Surgical Hypoparathyroidism
Idiopathic Hypoparathyroidism

7. Parathyroid Hormone Market Regional And Country Analysis

7.1. Global Parathyroid Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Parathyroid Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Parathyroid Hormone Market

8.1. Asia-Pacific Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Parathyroid Hormone Market

9.1. China Parathyroid Hormone Market Overview
9.2. China Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Parathyroid Hormone Market

10.1. India Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Parathyroid Hormone Market

11.1. Japan Parathyroid Hormone Market Overview
11.2. Japan Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Parathyroid Hormone Market

12.1. Australia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Parathyroid Hormone Market

13.1. Indonesia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Parathyroid Hormone Market

14.1. South Korea Parathyroid Hormone Market Overview
14.2. South Korea Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Parathyroid Hormone Market

15.1. Western Europe Parathyroid Hormone Market Overview
15.2. Western Europe Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Parathyroid Hormone Market

16.1. UK Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Parathyroid Hormone Market

17.1. Germany Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Parathyroid Hormone Market

18.1. France Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Parathyroid Hormone Market

19.1. Italy Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Parathyroid Hormone Market

20.1. Spain Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Parathyroid Hormone Market

21.1. Eastern Europe Parathyroid Hormone Market Overview
21.2. Eastern Europe Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Parathyroid Hormone Market

22.1. Russia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Parathyroid Hormone Market

23.1. North America Parathyroid Hormone Market Overview
23.2. North America Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Parathyroid Hormone Market

24.1. USA Parathyroid Hormone Market Overview
24.2. USA Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Parathyroid Hormone Market

25.1. Canada Parathyroid Hormone Market Overview
25.2. Canada Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Parathyroid Hormone Market

26.1. South America Parathyroid Hormone Market Overview
26.2. South America Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Parathyroid Hormone Market

27.1. Brazil Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Parathyroid Hormone Market

28.1. Middle East Parathyroid Hormone Market Overview
28.2. Middle East Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Parathyroid Hormone Market

29.1. Africa Parathyroid Hormone Market Overview
29.2. Africa Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Parathyroid Hormone Market Competitive Landscape And Company Profiles

30.1. Parathyroid Hormone Market Competitive Landscape
30.2. Parathyroid Hormone Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Radius Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Shire plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Ascendis Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Parathyroid Hormone Market Other Major And Innovative Companies

31.1. Entera Bio Ltd.
31.2. Extend Biosciences Inc.
31.3. Gedeon Richter Plc.
31.4. Abbott Laboratories
31.5. Amgen Inc.
31.6. Merck & Co. Inc.
31.7. Novartis AG
31.8. F. Hoffmann-La Roche AG
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Alcon Laboratories Inc.
31.11. Bayer Healthcare
31.12. Becton Dickinson and Company
31.13. Ethicon Inc.
31.14. Genentech Inc.
31.15. Medtronic Inc.

32. Global Parathyroid Hormone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Parathyroid Hormone Market

34. Recent Developments In The Parathyroid Hormone Market

35. Parathyroid Hormone Market High Potential Countries, Segments and Strategies

35.1 Parathyroid Hormone Market In 2029 - Countries Offering Most New Opportunities
35.2 Parathyroid Hormone Market In 2029 - Segments Offering Most New Opportunities
35.3 Parathyroid Hormone Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer